Two Zn(ii) complexes [Zn(L)(en)]ClO4 (1) and [Zn(L)2] (2) were synthesized and designed and their molecular docking with the SARS-CoV-2 RBD protein and Omicron spike protein were studied for assessing them as possible therapeutic drug candidates against SARS-CoV-2 and its Omicron variant.